Stay informed on issues important to patients of Montgomery Cancer Center.
Montgomery Cancer Center among first in nation to treat advanced prostate cancer patients with Provenge
Montgomery Cancer Center is the first facility in Alabama and among the first in the nation to treat advanced prostate cancer patients with a promising new therapy. Read More
Wed, 22 Oct 2014 00:01:38 +0000
FDA Grants Breakthrough Therapy Designation to AP26113 for ALK-Positive NSCLC
The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to an investigational agent AP26113 for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non–small cell lung cancer (NSCLC) who are resistant to Xalkori® (crizotinib) This designation is based on results from an ongoing phase I/II trial showing sustained antitumor activity of AP26113 in […]read more
The most state-of-the-art technology of its kind in Alabama, TrueBeam™ from Varian Medical Systems integrates advanced imaging and motion management technologies to target tumors with sub-millimeter accuracy – and short treatment times.
Take a minute to visit the campus of Montgomery Cancer Center - without leaving your computer. Take a tour.
© Montgomery Cancer Center, 4145 Carmichael Road Montgomery, AL 36106